Pharvaris NV (PHVS)
22.52
-0.16
(-0.71%)
USD |
NASDAQ |
May 07, 16:00
22.52
0.00 (0.00%)
After-Hours: 20:00
Pharvaris Cash from Operations (TTM): -100.74M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -100.74M |
September 30, 2023 | -99.12M |
June 30, 2023 | -87.02M |
March 31, 2023 | -77.84M |
December 31, 2022 | -70.83M |
September 30, 2022 | -62.02M |
June 30, 2022 | -59.81M |
Date | Value |
---|---|
March 31, 2022 | -60.54M |
December 31, 2021 | -52.77M |
September 30, 2021 | -47.68M |
June 30, 2021 | -44.57M |
March 31, 2021 | -34.28M |
December 31, 2020 | -24.55M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-100.74M
Minimum
Dec 2023
-24.55M
Maximum
Dec 2020
-63.21M
Average
-60.54M
Median
Mar 2022
Cash from Operations (TTM) Benchmarks
uniQure NV | -145.93M |
ProQR Therapeutics NV | 23.33M |
Merus NV | -142.21M |
argenx SE | -- |
Pharming Group | -17.30M |